Government unveils plan to reduce NHS waiting list backlog
The government pledged to cut the list of patients waiting more than 18 weeks for treatment in England by nearly half a million over the next year.
Related Articles
T cell malignancies after CAR T cell therapy in the DESCAR-T registry
Nature Medicine – This analysis of the registry database DESCAR-T of more than 3,000 pediatric and adult patients with hematological malignancies who received CAR T cell…
Use of a clinical trial screening tool to enhance patient accrual
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations
AbstractPurpose:. Cancer clinical trials often accrue slowly or miss enrollment targets. Strict eligibility criteria are a major reason. Restrictive criteria also limit opportunities for patient…
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group
AbstractPurpose:. Performance status (PS) is one of the most common eligibility criteria. Many trials are limited to patients with high-functioning PS, resulting in important differences…
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement
AbstractPurpose:. Restrictive clinical trial eligibility criteria (EC) limit the number of patients who can enroll and potentially benefit from protocol-driven, investigational treatment plans and reduce…
Make it your resolution to attend HOPE Summit in 2025 – LUNGevity Foundation – OncoDaily
Make it your resolution to attend HOPE Summit in 2025 – LUNGevity Foundation / cancer, HOPE Summit 2025, LUNGevity Foundation, OncoDaily, Oncology
More Work Needed to Overcome Racial, Ethnic AHCT Disparities in Multiple Myeloma | ASH Clinical News | American Society of Hematology
Katie Robinson is a medical writer based in New York. Autologous hematopoietic cell transplantation (AHCT) is a global standard of care for eligible patients with…
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
A conversation with Margaret McCartney, MD, PhD regarding evidence-based medicine and conflicts of interest
Listen now | A conversation with Margaret McCartney
Discovery of INCB159020, an Orally Bioavailable KRAS G12D Inhibitor
The inhibition of mutant KRAS proteins has emerged as a promising approach for treating KRAS-driven cancers, as evidenced by the clinical success of KRAS G12C…
